NCT06220435View on ClinicalTrials.gov

Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

September 1, 2031

Study Completion Date

September 1, 2031

Conditions
Prostate Cancer
Interventions
RADIATION

Ultra-hypofractionated radiotherapy regimen.

"* Prostate tumor(s): 49 Gray (Gy)/7 fractions~* Prostate gland: 42.7 Gy/7 fractions~* Elective lymph nodes: 29.4 Gy/7 fractions~* Seminal vesicles: 31.15 Gy/7 fractions"

Trial Locations (2)

Unknown

RECRUITING

Region Skåne, Skåne University Hospital, Lund

RECRUITING

Region Västerbotten, Umeå University Hospital, Umeå

All Listed Sponsors
lead

Region Skane

OTHER